India Close Second to China in Clinical trial registered to be conducted in Asia: A Dolcera Study
Clinical trials are conducted to allow safety and efficacy data to be collected for new drugs or devices. We did a comparative study for key Asian countries (India, China, Pakistan, Singapore and Sri Lanka) to better understand the trend of clinical trials in Asian countries. The numbers of trials, as registered with clinicaltrials.gov by companies all across the world were considered in this study.
1. India’s second largest pie share
India is close second to China (~41%) with 36% clinical trials being registered from 2002 to 2008, to be conducted in India. Singapore and Pakistan holds third and fourth position respectively in 5 nations comparison study. Sri Lanka has only 0.3% share in the pie.
2. Clinical trials in Asia on a rise
India has shown a whopping 463.33% growth from 2002 to 2008 in terms of clinical trials registered to be conducted in India. China follows close second with 365.56% rise in the same period. However, overall statistics showed that China remains number 1 for clinical trial destination amongst 5 countries.
3. Growth curve for clinical trials in top 3 Asian Countries
As apparent from our results India and China were head to head till the year 2006, following that China started getting lead from India. On the other hand, Singapore started losing to India and China following 2004.
Read Part-II of this study at : http://blogs.dolcera.com/blog/2009/07/21/clinical-tiral-in-asia-a-dolcera-study-part-ii/
- Harit Mohan
Knowledge Scientist
Dolcera
![[Post to Twitter]](http://blogs.dolcera.com/wp-content/plugins/tweet-this/icons/tt-twitter-micro2.png){kind=icon}
Tweet This Post ![[Post to Delicious]](http://blogs.dolcera.com/wp-content/plugins/tweet-this/icons/tt-delicious.png){kind=icon}
Delicious This Post ![[Post to Digg]](http://blogs.dolcera.com/wp-content/plugins/tweet-this/icons/tt-digg.png){kind=icon}
Digg This Post
July 21st, 2009 at 3:57 am
[…] from the previosuly published study on India Close Second to China in Clinical trial registered to be conducted in Asia: A Dolcera Study, we analysed 4 other important Asian countries and the trend of clinical trials there, these were: […]